These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 31694837)
1. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Jain N; Li AL; Yu Y; VanderBeek BL Br J Ophthalmol; 2020 Aug; 104(8):1093-1097. PubMed ID: 31694837 [TBL] [Abstract][Full Text] [Related]
2. Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States. Ludwig CA; Vail D; Callaway NF; Pasricha MV; Moshfeghi DM Ophthalmology; 2020 Apr; 127(4):535-543. PubMed ID: 31899034 [TBL] [Abstract][Full Text] [Related]
3. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation. Shah R; Simonett JM; Lyons RJ; Rao RC; Pennesi ME; Jain N JAMA Ophthalmol; 2020 Aug; 138(8):894-900. PubMed ID: 32644147 [TBL] [Abstract][Full Text] [Related]
4. PENTOSAN POLYSULFATE AND VISION: Findings from an International Survey of Exposed Individuals. Uner OE; Shah MK; Jain N Retina; 2021 Jul; 41(7):1562-1569. PubMed ID: 33332810 [TBL] [Abstract][Full Text] [Related]
10. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis. Wang D; Au A; Gunnemann F; Hilely A; Scharf J; Tran K; Sun M; Kim JH; Sarraf D Can J Ophthalmol; 2020 Apr; 55(2):116-125. PubMed ID: 31973791 [TBL] [Abstract][Full Text] [Related]
11. Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening. Wang D; Velaga SB; Grondin C; Au A; Nittala M; Chhablani J; Vupparaboina KK; Gunnemann F; Jung J; Kim JH; Ip M; Sadda S; Sarraf D Am J Ophthalmol; 2021 Jul; 227():125-138. PubMed ID: 33651989 [TBL] [Abstract][Full Text] [Related]
12. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice. Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330 [TBL] [Abstract][Full Text] [Related]
13. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy. Case AW; Anderson MJ; Sayomac LE Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907 [TBL] [Abstract][Full Text] [Related]
14. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation? Proctor JG Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330 [TBL] [Abstract][Full Text] [Related]
15. Association Between Pentosan Polysulfate Sodium and Retinal Disorders. McGwin G; MacLennan P; Owsley C JAMA Ophthalmol; 2022 Jan; 140(1):37-42. PubMed ID: 34792558 [TBL] [Abstract][Full Text] [Related]
16. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging. Christiansen JS; Barnes AC; Berry DE; Jain N Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504 [TBL] [Abstract][Full Text] [Related]